Join our migraine experts as they travel through today’s treatment landscape, with stops along the way to focus on common clinical questions related to the use of CGRP monoclonal antibodies (mAbs). You’ll see how they may consider alternate routes while sharing insights supported by scientific data. At the end of the journey, you will gain an understanding of how this team skillfully navigates migraine management.
Speakers:
Fred Cohen, MD
Morris Levin, MD, FAHS
Stephanie J. Nahas, MD, MSEd, FAHS
Hope O’Brien, MD, MBA
